Mutation or deletion of A20 gene exists in nearly 40% of HL cases, contributing to constitutive NF-κB activity in cHL cells, while A20 reconstitution confers cytotoxicity to A20-deficient cHL cells [177–179]. The gene discussed is NFKB1; the disease is classic Hodgkin lymphoma.